New testing and treatment options for common sexually transmitted diseases (STDs) are emerging, including at-home tests for gonorrhea, chlamydia, and HPV, as well as new oral medications for gonorrhea. These developments aim to reduce infection rates in the US, which had surged during the COVID-19 pandemic. Experts express optimism about increased accessibility and convenience, but caution about potential challenges such as higher costs and funding cuts to public health agencies. Teljes cikk (Euronews.com)